Related Experiment Videos
Essential oils and their constituents: anticonvulsant activity
Reinaldo Nóbrega de Almeida1, Maria de Fátima Agra, Flávia Negromonte Souto Maior
1Laboratório de Tecnologia Farmacêutica, Federal University of Paraíba, Caixa Postal 5009, CEP 58051-970, João Pessoa, PB, Brazil. reinaldoan@uol.com.br
Molecules (Basel, Switzerland)
|March 29, 2011
Summary
This study surveyed plants with anticonvulsant activity, identifying 30 species and 30 essential oil constituents. These findings highlight natural sources for potential epilepsy treatments.
Area of Science:
- Phytochemistry
- Pharmacology
- Natural Products
Background:
- Epilepsy treatment often relies on synthetic drugs with potential side effects.
- Natural products, particularly plant-derived essential oils, represent a promising area for novel anticonvulsant drug discovery.
Purpose of the Study:
- To conduct a comprehensive literature review of plant species and their essential oils exhibiting anticonvulsant activity.
- To identify and document plant species, families, genera, and specific chemical constituents with demonstrated anticonvulsant properties.
Main Methods:
- A literature-based survey was performed using scientific databases.
- Data extraction focused on studies reporting anticonvulsant activity in experimental models.
- Information on plant species, essential oil composition, and bioactive compounds was compiled.
Main Results:
- Thirty plant species from 13 families and 23 genera were identified with anticonvulsant activity.
- Thirty distinct chemical constituents within these essential oils were described as having anticonvulsant properties.
- Detailed information on the identified species and their isolated bioactive compounds was presented.
Conclusions:
- A significant number of plant species and their essential oil constituents possess anticonvulsant potential.
- This review provides a valuable resource for researchers exploring natural product-based anticonvulsant therapies.
- Further investigation into these identified natural compounds could lead to the development of new anti-epileptic drugs.
Related Concept Videos
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...